Granite Group Advisors’s AbbVie ABBV Stock Holding History

Granite Group Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$815K	Sell	3,115 -832	-21%	-$213K	0.52%	33
2026 Q2	$993K	Buy	3,947 +10	+0.3%	+$2.15K	0.59%	33
2026 Q1	$813K	Buy	3,937 +161	+4%	+$35.7K	0.49%	36
2025 Q4	$863K	Sell	3,776 -136	-3%	-$31K	0.49%	33
2025 Q3	$906K	Buy	3,912 +8	+0.2%	+$1.63K	0.55%	29
2025 Q2	$725K	Hold	3,904	–	–	0.44%	29
2025 Q1	$818K	Sell	3,904 -4,203	-52%	-$817K	0.57%	29
2024 Q4	$1.44M	Buy	8,107 +34	+0.4%	+$6.25K	0.92%	25
2024 Q3	$1.59M	Sell	8,073 -3,967	-33%	-$740K	1.02%	22
2024 Q2	$2.07M	Buy	12,040 +244	+2%	+$40.4K	1.56%	17
2024 Q1	$2.15M	Sell	11,796 -79	-0.7%	-$13.6K	1.45%	15
2023 Q4	$2.13M	Buy	+11,875	New	+$1.73M	1.51%	15

Other funds holding ABBV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Granite Group Advisors's ABBV Position: Q3 2026 in Review

Granite Group Advisors reduced its AbbVie (ABBV) stake by 21% in Q3 2026, selling an estimated $213K and leaving 3,115 shares worth $815K. The position accounts for 0.52% of the portfolio, ranked #33.

Granite Group Advisors first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.15M in Q1 2024. 2,874 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Granite Group Advisors held 3,115 shares of AbbVie worth $815K as of Q3 2026.
Granite Group Advisors sold 832 AbbVie shares in Q3 2026, an estimated $213K.
AbbVie made up 0.52% of Granite Group Advisors's portfolio in Q3 2026, its #33 holding.
Granite Group Advisors first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
Granite Group Advisors's AbbVie position peaked at $2.15M in Q1 2024.
2,874 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Granite Group Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.